secwatch.observer — SEC 8-K summary
======================================

Issuer:     OptimizeRx Corp (OPRX)
CIK:        0001448431
Form:       8-K
Filed at:   2024-06-07T23:59:59+00:00
Accession:  0001213900-24-050753
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

OptimizeRx shareholders approve 1.95M share increase to equity plan at annual meeting
--------------------------------------------------------------------------------

- Shareholders approved amendment to 2021 Equity Plan increasing share pool from 2.5M to 4.45M shares (increase of 1.95M).
- Equity plan vote: 10,129,247 for, 3,425,566 against, 8,853 abstain, 1,966,973 broker non-votes.
- All six director nominees elected; advisory say-on-pay approved with 8,790,190 for votes.
- UHY LLP ratified as independent auditor for fiscal 2024 with 13,628,263 votes for, 24,012 against, 1,878,364 abstain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1448431/000121390024050753/0001213900-24-050753-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1448431/000121390024050753/ea0207524-8k_optimize.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-050753

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer